Chenglong Han

Chenglong Han

UNVERIFIED PROFILE

Are you Chenglong Han?   Register this Author

Register author
Chenglong Han

Chenglong Han

Publications by authors named "Chenglong Han"

Are you Chenglong Han?   Register this Author

36Publications

704Reads

7Profile Views

Efficacy and safety of guselkumab, administered with a novel patient-controlled injector (One-Press), for moderate-to-severe psoriasis: results from the phase 3 ORION study.

J Dermatolog Treat 2019 Mar 19:1-8. Epub 2019 Mar 19.

g Department of Dermatology, Venereology and Allergology , Wroclaw Medical University , Wrocław , Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/09546634.2019.1587145DOI Listing
March 2019

Evaluation of surgery plus postoperative radiotherapy or definitive radiotherapy in older patients with thoracic esophageal squamous cell cancer.

J Cancer Res Ther 2019 ;15(4):849-856

Department of Radiotherapy, The First Affiliated Hospital of Nanjing Medical College, Nanjing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/jcrt.JCRT_789_18DOI Listing
January 2019

Prognosis value of MGMT promoter methylation for patients with lung cancer: a meta-analysis.

Int J Clin Exp Pathol 2015 1;8(9):11560-4. Epub 2015 Sep 1.

Department of Respiratory Medicine, Jiangyin Hospital of Traditional Chinese Medicine, Nanjing Traditional Chinese Medcine University Jiangyin 214400, China.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637707PMC
December 2016

Safety and Efficacy of Subcutaneous Golimumab in Patients with Active Rheumatoid Arthritis despite Methotrexate Therapy: Final 5-year Results of the GO-FORWARD Trial.

J Rheumatol 2016 Feb 15;43(2):298-306. Epub 2015 Dec 15.

From Immunology and Rheumatology, University of Toronto and Mount Sinai Hospital, Toronto, Ontario, Canada; Immunology and Rheumatology, Stanford University, Palo Alto, California; Janssen Global Services LLC, Malvern, Pennsylvania, USA; Biostatistics, Janssen Research & Development LLC, Malvern; Biologics Clinical Pharmacology, and Immunology, Janssen Research & Development LLC, Spring House, Pennsylvania, USA; Rheumatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA; Rheumatology, Cabrini Medical Centre, Malvern, Australia; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.E.C. Keystone, MD, FRCP(C), Immunology and Rheumatology, University of Toronto and Mount Sinai Hospital; M.C. Genovese, MD, Immunology and Rheumatology, Stanford University; S. Hall, MBBS, FRACP, Rheumatology, Cabrini Medical Centre; S.C. Bae, MD, PhD, MPH, Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases; C. Han, PhD, Janssen Global Services LLC; T.A. Gathany, MEd, Janssen Global Services LLC; S. Xu, MS, Biostatistics, Janssen Research & Development LLC; Y. Zhou, PhD, Biostatistics, Janssen Research & Development LLC; J.H. Leu, PhD, Biologics Clinical Pharmacology, Janssen Research & Development LLC; E.C. Hsia, MD, Immunology, Janssen Research & Development LLC, and Rheumatology, University of Pennsylvania School of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.150712DOI Listing
February 2016

Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trial.

Rheumatology (Oxford) 2014 Sep 11;53(9):1654-63. Epub 2014 Apr 11.

Shanghai Renji Hospital, Shanghai, Chinese PLA General Hospital, Beijing, China, Case Western Reserve University, Cleveland, OH, Janssen Research & Development, LLC, Spring House, PA and University of Pennsylvania School of Medicine, Philadelphia, PA, USA. hap//contradistinctionst2/show/NCT01248793Shanghai Renji Hospital, Shanghai, Chinese PLA General Hospital, Beijing, China, Case Western Reserve University, Cleveland, OH, Janssen Research & Development, LLC, Spring House, PA and University of Pennsylvania School of Medicine, Philadelphia, PA, USA. hap//contradistinctionst2/show/NCT01248793.

View Article

Download full-text PDF

Source
https://academic.oup.com/rheumatology/article-lookup/doi/10.
Publisher Site
http://dx.doi.org/10.1093/rheumatology/keu132DOI Listing
September 2014

The effect of golimumab therapy on disease activity and health-related quality of life in patients with ankylosing spondylitis: 2-year results of the GO-RAISE trial.

J Rheumatol 2014 Jun 15;41(6):1095-103. Epub 2014 Apr 15.

From the Rheumatology Department, Leiden University Medical Center, Leiden, The Netherlands; Oregon Health and Science University, Portland, Oregon, USA; Rheumazentrum Ruhrgebiet, Herne, Germany; Biostatistics and Immunology, Janssen Research & Development LLC, Spring House; Janssen Global Services, Malvern, Pennsylvania, USA; Department of Medicine and Immunology, University of Toronto, Toronto, Ontario, Canada.D. van der Heijde, MD, Rheumatology Department, Leiden University Medical Center; A. Deodhar, MD, Oregon Health & Science University; J. Braun, MD, Rheumazentrum Ruhrgebiet; M. Mack, PhD, Biostatistics, Janssen Research & Development LLC; B. Hsu, MD, PhD, Immunology, Janssen Research & Development LLC; T.A. Gathany, MSEd, Janssen Global Services; R.D. Inman, MD, FRCPC, FACP, FRCP Edin, Department of Medicine and Immunology, University of Toronto; C. Han, PhD, Janssen Global Services.

View Article

Download full-text PDF

Source
http://www.jrheum.org/cgi/doi/10.3899/jrheum.131003
Publisher Site
http://dx.doi.org/10.3899/jrheum.131003DOI Listing
June 2014

The effect of intravenous golimumab on health-related quality of life in rheumatoid arthritis: 24-week results of the phase III GO-FURTHER trial.

J Rheumatol 2014 Jun 1;41(6):1067-76. Epub 2014 May 1.

From the Division of Rheumatology and Allergy and Clinical Immunology, Johns Hopkins University, Baltimore, Maryland; Department of Clinical Rheumatology, Brigham and Women's Hospital, Boston, Massachusetts; Patient Reported Outcomes, Janssen Global Services LLC, Malvern, Pennsylvania; Biostatistics and Immunology, Janssen Research & Development LLC, Spring House, Pennsylvania, USA; Department of Rheumatology, UZ Gasthuisberg, KU Leuven, Belgium.C.O. Bingham III, MD, Division of Rheumatology and Allergy and Clinical Immunology, Johns Hopkins University; M. Weinblatt, MD, Department of Clinical Rheumatology, Brigham and Women's Hospital; C. Han, PhD; T.A. Gathany, PhD, Patient Reported Outcomes, Janssen Global Services; L. Kim, PhD; K.H. Lo, PhD, Biostatistics, Janssen Research & Development LLC; D. Baker, MD; A. Mendelsohn, MD, Immunology, Janssen Research & Development LLC; R. Westhovens, MD, Department of Rheumatology, University Hospitals Leuven; Department of Development and Regeneration, KU Leuven.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.130864DOI Listing
June 2014

Increased prevalence of psychiatric disorders and health care-associated costs among patients with moderate-to-severe psoriasis.

J Drugs Dermatol 2011 Aug;10(8):843-50

Janssen Global Services, LLC, Malvern, PA, USA.

View Article

Download full-text PDF

Source
August 2011

[Research progress of nucleus pulposus cells phenotypic markers].

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2011 Jul;25(7):867-70

Department of Orthopaedics, the First Affiliated Hospital of Harbin Medical University, Harbin Heilongjiang, 150001, P.R.China.

View Article

Download full-text PDF

Source
July 2011

Comparison of employability outcomes among patients with early or long-standing rheumatoid arthritis.

Arthritis Rheum 2008 Apr;59(4):510-4

Centocor Research and Development, Malvern, Pennsylvania 19355, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.23541DOI Listing
April 2008

Association of anemia and physical disability among patients with rheumatoid arthritis.

J Rheumatol 2007 Nov 15;34(11):2177-82. Epub 2007 Oct 15.

Centocor Research and Development Inc., 200 Great Valley Parkway, Malvern, PA 19355, USA.

View Article

Download full-text PDF

Source
November 2007

Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

J Rheumatol 2006 Nov 1;33(11):2167-72. Epub 2006 Sep 1.

Centocor Inc., Malvern, PA 19335, USA.

View Article

Download full-text PDF

Source
November 2006

Crack cocaine and sex.

J Psychoactive Drugs 2004 Sep;36(3):315-22

School of Nursing, University of Maryland, Baltimore, Maryland 21201, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/abs/10.1080/02791072.2004.104
Publisher Site
http://dx.doi.org/10.1080/02791072.2004.10400032DOI Listing
September 2004

Functional status and radiographic joint damage are associated with health economic outcomes in patients with rheumatoid arthritis.

J Rheumatol 2004 May;31(5):849-55

Center for Innovative Therapy, Division of Rheumatology, Allergy and Immunology, University of California at San Diego, La Jolla, California 92093, USA.

View Article

Download full-text PDF

Source
http://www.jrheum.org/content/31/5/849.full.pdf
Web Search
May 2004

Infliximab improves quality of life in patients with Crohn's disease.

Inflamm Bowel Dis 2002 Jul;8(4):237-43

Department of Medicine, Division of Gastroenterology, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia 19104-4283, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00054725-200207000-00001DOI Listing
July 2002